Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.64810144 |
2 | synaptic vesicle maturation (GO:0016188) | 4.59374227 |
3 | synaptic vesicle exocytosis (GO:0016079) | 4.43774318 |
4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.38429703 |
5 | neuronal action potential propagation (GO:0019227) | 4.34500644 |
6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.25059124 |
7 | COPI coating of Golgi vesicle (GO:0048205) | 4.16479566 |
8 | Golgi transport vesicle coating (GO:0048200) | 4.16479566 |
9 | glutamate secretion (GO:0014047) | 4.05625992 |
10 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.05285478 |
11 | NADH metabolic process (GO:0006734) | 3.81149999 |
12 | regulation of synaptic vesicle transport (GO:1902803) | 3.77176772 |
13 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.74342096 |
14 | axon ensheathment in central nervous system (GO:0032291) | 3.73076166 |
15 | central nervous system myelination (GO:0022010) | 3.73076166 |
16 | locomotory exploration behavior (GO:0035641) | 3.68633400 |
17 | cellular potassium ion homeostasis (GO:0030007) | 3.63214712 |
18 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.57610501 |
19 | protein retention in ER lumen (GO:0006621) | 3.53114460 |
20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.52127307 |
21 | proline biosynthetic process (GO:0006561) | 3.48584274 |
22 | vocalization behavior (GO:0071625) | 3.42017386 |
23 | neuron cell-cell adhesion (GO:0007158) | 3.39485938 |
24 | protein localization to synapse (GO:0035418) | 3.36962277 |
25 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.33600036 |
26 | negative regulation of catenin import into nucleus (GO:0035414) | 3.33302721 |
27 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.27495752 |
28 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.22250505 |
29 | low-density lipoprotein particle clearance (GO:0034383) | 3.21558549 |
30 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.16781359 |
31 | neurotransmitter secretion (GO:0007269) | 3.16338564 |
32 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.15602976 |
33 | protein maturation by protein folding (GO:0022417) | 3.15228171 |
34 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.14315260 |
35 | desmosome organization (GO:0002934) | 3.11085443 |
36 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.10332861 |
37 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.06869384 |
38 | neuromuscular process controlling posture (GO:0050884) | 3.06172570 |
39 | gamma-aminobutyric acid transport (GO:0015812) | 3.05751253 |
40 | alpha-linolenic acid metabolic process (GO:0036109) | 3.04675375 |
41 | regulation of synapse structural plasticity (GO:0051823) | 3.03840406 |
42 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.02668996 |
43 | layer formation in cerebral cortex (GO:0021819) | 3.01913607 |
44 | exploration behavior (GO:0035640) | 3.00078935 |
45 | transmission of nerve impulse (GO:0019226) | 2.99489392 |
46 | synaptic transmission, glutamatergic (GO:0035249) | 2.98841535 |
47 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.98595107 |
48 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.98392888 |
49 | mitotic nuclear envelope reassembly (GO:0007084) | 2.97592389 |
50 | nuclear envelope reassembly (GO:0031468) | 2.97592389 |
51 | proline transport (GO:0015824) | 2.95335167 |
52 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.93659912 |
53 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.93659912 |
54 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.92081136 |
55 | mating behavior (GO:0007617) | 2.91550301 |
56 | cellular copper ion homeostasis (GO:0006878) | 2.89661452 |
57 | DNA strand renaturation (GO:0000733) | 2.89098565 |
58 | sodium ion export (GO:0071436) | 2.87738064 |
59 | neuron-neuron synaptic transmission (GO:0007270) | 2.87493052 |
60 | glutamate receptor signaling pathway (GO:0007215) | 2.87441460 |
61 | positive regulation of membrane potential (GO:0045838) | 2.87344219 |
62 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.86997437 |
63 | regulation of vesicle fusion (GO:0031338) | 2.86214387 |
64 | barbed-end actin filament capping (GO:0051016) | 2.85414594 |
65 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.83808458 |
66 | epithelial cell-cell adhesion (GO:0090136) | 2.82562773 |
67 | neuron recognition (GO:0008038) | 2.81554488 |
68 | regulation of cholesterol storage (GO:0010885) | 2.81464551 |
69 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.80520087 |
70 | neurotransmitter transport (GO:0006836) | 2.79045290 |
71 | regulation of sequestering of triglyceride (GO:0010889) | 2.78219698 |
72 | triglyceride catabolic process (GO:0019433) | 2.77497040 |
73 | triglyceride biosynthetic process (GO:0019432) | 2.77368329 |
74 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.76246985 |
75 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.75911416 |
76 | fatty acid homeostasis (GO:0055089) | 2.72565206 |
77 | mitochondrial fusion (GO:0008053) | 2.70344732 |
78 | glycine transport (GO:0015816) | 2.70257586 |
79 | transferrin transport (GO:0033572) | 2.69782724 |
80 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.68290505 |
81 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.68173296 |
82 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.67537662 |
83 | regulation of neurotransmitter secretion (GO:0046928) | 2.67441041 |
84 | peroxisome fission (GO:0016559) | 2.66994291 |
85 | detection of calcium ion (GO:0005513) | 2.66963053 |
86 | dendritic spine morphogenesis (GO:0060997) | 2.66690651 |
87 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.64562117 |
88 | tricarboxylic acid cycle (GO:0006099) | 2.63703265 |
89 | negative regulation of neurotransmitter transport (GO:0051589) | 2.63327803 |
90 | activation of protein kinase A activity (GO:0034199) | 2.62735030 |
91 | regulation of synaptic plasticity (GO:0048167) | 2.62680450 |
92 | neuronal ion channel clustering (GO:0045161) | 2.61757746 |
93 | long-term memory (GO:0007616) | 2.61490815 |
94 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.61256482 |
95 | neutral lipid biosynthetic process (GO:0046460) | 2.60740953 |
96 | acylglycerol biosynthetic process (GO:0046463) | 2.60740953 |
97 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.59651583 |
98 | negative regulation of protein localization to cell surface (GO:2000009) | 2.59607073 |
99 | potassium ion import (GO:0010107) | 2.58922456 |
100 | adult walking behavior (GO:0007628) | 2.58700618 |
101 | neutral lipid catabolic process (GO:0046461) | 2.58275850 |
102 | acylglycerol catabolic process (GO:0046464) | 2.58275850 |
103 | regulation of oxidative phosphorylation (GO:0002082) | 2.56886275 |
104 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.54750351 |
105 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.54719356 |
106 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.54481191 |
107 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.54111411 |
108 | regulation of neurotransmitter levels (GO:0001505) | 2.53659516 |
109 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.53603911 |
110 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.53514727 |
111 | calcium ion-dependent exocytosis (GO:0017156) | 2.53056243 |
112 | negative regulation of amino acid transport (GO:0051956) | 2.52959496 |
113 | potassium ion homeostasis (GO:0055075) | 2.52641626 |
114 | trivalent inorganic cation transport (GO:0072512) | 2.52208396 |
115 | ferric iron transport (GO:0015682) | 2.52208396 |
116 | acyl-CoA biosynthetic process (GO:0071616) | 2.51445643 |
117 | thioester biosynthetic process (GO:0035384) | 2.51445643 |
118 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.51382524 |
119 | protein targeting to plasma membrane (GO:0072661) | 2.51284427 |
120 | apoptotic cell clearance (GO:0043277) | 2.51235548 |
121 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.50513878 |
122 | establishment of mitochondrion localization (GO:0051654) | 2.50315862 |
123 | L-amino acid import (GO:0043092) | 2.49446233 |
124 | dendrite morphogenesis (GO:0048813) | 2.48952392 |
125 | pentose-phosphate shunt (GO:0006098) | 2.48874100 |
126 | regulation of glutamate secretion (GO:0014048) | 2.48824797 |
127 | neuromuscular process controlling balance (GO:0050885) | 2.48466378 |
128 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.48279612 |
129 | vesicle transport along microtubule (GO:0047496) | 2.47396681 |
130 | positive regulation of potassium ion transport (GO:0043268) | 2.47229547 |
131 | regulation of neurotransmitter transport (GO:0051588) | 2.46945293 |
132 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.46320076 |
133 | organelle transport along microtubule (GO:0072384) | 2.46103941 |
134 | regulation of postsynaptic membrane potential (GO:0060078) | 2.45973812 |
135 | membrane hyperpolarization (GO:0060081) | 2.45798709 |
136 | tight junction assembly (GO:0070830) | 2.45661524 |
137 | regulation of early endosome to late endosome transport (GO:2000641) | 2.45498974 |
138 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.45476357 |
139 | presynaptic membrane assembly (GO:0097105) | 2.44604639 |
140 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.44214222 |
141 | glucose catabolic process (GO:0006007) | 2.43820060 |
142 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.43532663 |
143 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.43532663 |
144 | carnitine shuttle (GO:0006853) | 2.43429677 |
145 | presynaptic membrane organization (GO:0097090) | 2.42869340 |
146 | long-term synaptic potentiation (GO:0060291) | 2.42853118 |
147 | positive regulation of exocytosis (GO:0045921) | 2.42744296 |
148 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.42674301 |
149 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.41257286 |
150 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.41117365 |
151 | L-phenylalanine metabolic process (GO:0006558) | 2.41117365 |
152 | membrane repolarization (GO:0086009) | 2.40936085 |
153 | positive regulation of receptor recycling (GO:0001921) | 2.39915536 |
154 | protein localization to endosome (GO:0036010) | 2.39775866 |
155 | synaptic vesicle endocytosis (GO:0048488) | 2.39775617 |
156 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.39519864 |
157 | cerebellar granule cell differentiation (GO:0021707) | 2.39306389 |
158 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.39257262 |
159 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.39251270 |
160 | regulation of exocytosis (GO:0017157) | 2.38932638 |
161 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.38840464 |
162 | ribosomal small subunit biogenesis (GO:0042274) | 2.38603178 |
163 | axonal fasciculation (GO:0007413) | 2.38598726 |
164 | cell communication by electrical coupling (GO:0010644) | 2.38307842 |
165 | L-serine transport (GO:0015825) | 2.38162448 |
166 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.37157009 |
167 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.37061678 |
168 | NADPH regeneration (GO:0006740) | 2.37054228 |
169 | positive regulation of actin filament depolymerization (GO:0030836) | 2.36936017 |
170 | amyloid precursor protein catabolic process (GO:0042987) | 2.36034395 |
171 | response to muscle activity (GO:0014850) | 2.35207081 |
172 | amyloid precursor protein metabolic process (GO:0042982) | 2.34143761 |
173 | tricarboxylic acid metabolic process (GO:0072350) | 2.34086278 |
174 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.33641390 |
175 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.32107481 |
176 | glycogen catabolic process (GO:0005980) | 2.31553606 |
177 | heme biosynthetic process (GO:0006783) | 2.29833239 |
178 | receptor recycling (GO:0001881) | 2.26910850 |
179 | regulation of cellular respiration (GO:0043457) | 2.26219240 |
180 | intestinal epithelial cell development (GO:0060576) | 2.25610849 |
181 | cGMP-mediated signaling (GO:0019934) | 2.25607059 |
182 | regulation of protein localization to cell surface (GO:2000008) | 2.24903335 |
183 | muscle cell migration (GO:0014812) | 2.24621247 |
184 | glucan catabolic process (GO:0009251) | 2.24033800 |
185 | sarcomere organization (GO:0045214) | 2.23522388 |
186 | negative regulation of granulocyte differentiation (GO:0030853) | 2.20720155 |
187 | linoleic acid metabolic process (GO:0043651) | 2.20124351 |
188 | stress fiber assembly (GO:0043149) | 2.19579738 |
189 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.19575426 |
190 | triglyceride metabolic process (GO:0006641) | 2.19539811 |
191 | proline metabolic process (GO:0006560) | 2.18604870 |
192 | heme metabolic process (GO:0042168) | 2.18358938 |
193 | urea cycle (GO:0000050) | 2.17804493 |
194 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.16646766 |
195 | tetrapyrrole biosynthetic process (GO:0033014) | 2.16294302 |
196 | beta-amyloid metabolic process (GO:0050435) | 2.16198996 |
197 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.16016798 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.70197934 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.33636353 |
3 | ZNF263_19887448_ChIP-Seq_K562_Human | 4.29667663 |
4 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.26444582 |
5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.16680050 |
6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.96158180 |
7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.87320096 |
8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.78391288 |
9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.77735969 |
10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.70046812 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.65281450 |
12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.65149090 |
13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.61888639 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.61197045 |
15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.60128395 |
16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.57588243 |
17 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.56697122 |
18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.47463119 |
19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.45513547 |
20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.45513547 |
21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.44390721 |
22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42728699 |
23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.35837792 |
24 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.35399241 |
25 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.31973785 |
26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.29149077 |
27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.25158871 |
28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.23317616 |
29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.20651290 |
30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18381522 |
31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.15155751 |
32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.08996262 |
33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.06393439 |
34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.00292033 |
35 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.99453071 |
36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98757396 |
37 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94786665 |
38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.89623062 |
39 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.86176292 |
40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85422480 |
41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.84727840 |
42 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.82352079 |
43 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.73198258 |
44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.68727918 |
45 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.64952008 |
46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64935626 |
47 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.64160974 |
48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.63314906 |
49 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.62998086 |
50 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62395493 |
51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.60658005 |
52 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.53839157 |
53 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.52580919 |
54 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.52112073 |
55 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.51702251 |
56 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.50779511 |
57 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.50295029 |
58 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.50193533 |
59 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.50015923 |
60 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.49978270 |
61 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.48757479 |
62 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.48189689 |
63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46328461 |
64 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.44959074 |
65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.44788941 |
66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.44217162 |
67 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.42600846 |
68 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.42481093 |
69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41765946 |
70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.41740551 |
71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40701620 |
72 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.40472702 |
73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39944201 |
74 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.36643788 |
75 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36574662 |
76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35217602 |
77 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.34562648 |
78 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.34255702 |
79 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32369011 |
80 | ATF3_27146783_Chip-Seq_COLON_Human | 1.31394721 |
81 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.30797598 |
82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30013541 |
83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28260304 |
84 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28163410 |
85 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28058450 |
86 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.26781746 |
87 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24086817 |
88 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23692313 |
89 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23664653 |
90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.22855404 |
91 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.22478285 |
92 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.21705786 |
93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21599467 |
94 | VDR_22108803_ChIP-Seq_LS180_Human | 1.20675060 |
95 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.20575683 |
96 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.20288684 |
97 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.20206393 |
98 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.20206393 |
99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19777321 |
100 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18814938 |
101 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.18667959 |
102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18655027 |
103 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.18099571 |
104 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17957979 |
105 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.16639319 |
106 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16216279 |
107 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.16049852 |
108 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15763467 |
109 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.15568161 |
110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14789362 |
111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14427014 |
112 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14424912 |
113 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14170092 |
114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.13328134 |
115 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.12675021 |
116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.12521254 |
117 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11784288 |
118 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11463849 |
119 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.10461154 |
120 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.09375801 |
121 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.07180709 |
122 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.07001216 |
123 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.06698164 |
124 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06532289 |
125 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05617531 |
126 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.04872760 |
127 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.04673415 |
128 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.04117933 |
129 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03687069 |
130 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03684473 |
131 | P300_19829295_ChIP-Seq_ESCs_Human | 1.03674751 |
132 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02929277 |
133 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02794250 |
134 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02687219 |
135 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01454499 |
136 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01404067 |
137 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01342772 |
138 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00982168 |
139 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.00709513 |
140 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00663384 |
141 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00598765 |
142 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.00292138 |
143 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.99852741 |
144 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.99631436 |
145 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99481415 |
146 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.99312683 |
147 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99095566 |
148 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99095566 |
149 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98604512 |
150 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.97359105 |
151 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96583495 |
152 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96060659 |
153 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94838185 |
154 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94530104 |
155 | KDM2B_26808549_Chip-Seq_K562_Human | 0.93790195 |
156 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93697092 |
157 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93288754 |
158 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93249154 |
159 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93145805 |
160 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91976977 |
161 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91768378 |
162 | AR_19668381_ChIP-Seq_PC3_Human | 0.86701995 |
163 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.86024133 |
164 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85010064 |
165 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83682417 |
166 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83670490 |
167 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.83374119 |
168 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83204045 |
169 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83194449 |
170 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81798773 |
171 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.81716459 |
172 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81557568 |
173 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81540977 |
174 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.80840701 |
175 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80602928 |
176 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80406912 |
177 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.80372951 |
178 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.80059512 |
179 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.79550744 |
180 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.79399090 |
181 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78751067 |
182 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78751067 |
183 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.77780120 |
184 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.77113674 |
185 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.76936497 |
186 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.76204174 |
187 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.75815249 |
188 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75582423 |
189 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.75126699 |
190 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.75016672 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.09158559 |
2 | MP0003880_abnormal_central_pattern | 4.34109741 |
3 | MP0004270_analgesia | 3.99877887 |
4 | MP0003635_abnormal_synaptic_transmissio | 3.39996391 |
5 | MP0005670_abnormal_white_adipose | 3.20947241 |
6 | MP0003329_amyloid_beta_deposits | 3.08542938 |
7 | MP0010234_abnormal_vibrissa_follicle | 2.89886938 |
8 | MP0002064_seizures | 2.83446808 |
9 | MP0009745_abnormal_behavioral_response | 2.77617517 |
10 | MP0004130_abnormal_muscle_cell | 2.73433447 |
11 | MP0002063_abnormal_learning/memory/cond | 2.65170077 |
12 | MP0003191_abnormal_cellular_cholesterol | 2.63764526 |
13 | MP0001968_abnormal_touch/_nociception | 2.61975726 |
14 | MP0002734_abnormal_mechanical_nocicepti | 2.55392225 |
15 | MP0002272_abnormal_nervous_system | 2.54956613 |
16 | MP0003705_abnormal_hypodermis_morpholog | 2.54828239 |
17 | MP0004185_abnormal_adipocyte_glucose | 2.41995081 |
18 | MP0003566_abnormal_cell_adhesion | 2.41992943 |
19 | MP0009046_muscle_twitch | 2.40445787 |
20 | MP0004233_abnormal_muscle_weight | 2.24510908 |
21 | MP0002572_abnormal_emotion/affect_behav | 2.22277122 |
22 | MP0001486_abnormal_startle_reflex | 2.19260705 |
23 | MP0002735_abnormal_chemical_nociception | 2.16650741 |
24 | MP0002796_impaired_skin_barrier | 2.15350000 |
25 | MP0002733_abnormal_thermal_nociception | 2.14512776 |
26 | MP0004043_abnormal_pH_regulation | 2.09252868 |
27 | MP0000920_abnormal_myelination | 2.09070398 |
28 | MP0004858_abnormal_nervous_system | 2.03552440 |
29 | MP0001440_abnormal_grooming_behavior | 2.03382641 |
30 | MP0002909_abnormal_adrenal_gland | 2.01547148 |
31 | MP0002877_abnormal_melanocyte_morpholog | 2.00217439 |
32 | MP0001970_abnormal_pain_threshold | 1.99139394 |
33 | MP0003941_abnormal_skin_development | 1.97984274 |
34 | MP0002736_abnormal_nociception_after | 1.96000462 |
35 | MP0005257_abnormal_intraocular_pressure | 1.95582812 |
36 | MP0005501_abnormal_skin_physiology | 1.93211247 |
37 | MP0001501_abnormal_sleep_pattern | 1.93072974 |
38 | MP0004885_abnormal_endolymph | 1.92756530 |
39 | MP0003656_abnormal_erythrocyte_physiolo | 1.91255286 |
40 | MP0002822_catalepsy | 1.86733916 |
41 | MP0005423_abnormal_somatic_nervous | 1.86399818 |
42 | MP0009379_abnormal_foot_pigmentation | 1.84971452 |
43 | MP0005666_abnormal_adipose_tissue | 1.84774419 |
44 | MP0008438_abnormal_cutaneous_collagen | 1.83936167 |
45 | MP0005464_abnormal_platelet_physiology | 1.80682068 |
46 | MP0000604_amyloidosis | 1.79991078 |
47 | MP0003186_abnormal_redox_activity | 1.79293729 |
48 | MP0002971_abnormal_brown_adipose | 1.76288509 |
49 | MP0000751_myopathy | 1.75298594 |
50 | MP0001905_abnormal_dopamine_level | 1.73102324 |
51 | MP0009780_abnormal_chondrocyte_physiolo | 1.70613191 |
52 | MP0002067_abnormal_sensory_capabilities | 1.70434336 |
53 | MP0004272_abnormal_basement_membrane | 1.69273924 |
54 | MP0000749_muscle_degeneration | 1.67537826 |
55 | MP0006276_abnormal_autonomic_nervous | 1.62157214 |
56 | MP0004147_increased_porphyrin_level | 1.57024328 |
57 | MP0003690_abnormal_glial_cell | 1.55734697 |
58 | MP0004134_abnormal_chest_morphology | 1.54603353 |
59 | MP0005165_increased_susceptibility_to | 1.53623405 |
60 | MP0003634_abnormal_glial_cell | 1.53165660 |
61 | MP0001529_abnormal_vocalization | 1.51868842 |
62 | MP0000778_abnormal_nervous_system | 1.50342063 |
63 | MP0000343_altered_response_to | 1.49977356 |
64 | MP0004087_abnormal_muscle_fiber | 1.49602334 |
65 | MP0004924_abnormal_behavior | 1.49098416 |
66 | MP0005386_behavior/neurological_phenoty | 1.49098416 |
67 | MP0000013_abnormal_adipose_tissue | 1.47824064 |
68 | MP0000955_abnormal_spinal_cord | 1.47076833 |
69 | MP0006036_abnormal_mitochondrial_physio | 1.46341360 |
70 | MP0005408_hypopigmentation | 1.46174529 |
71 | MP0009053_abnormal_anal_canal | 1.46019995 |
72 | MP0003806_abnormal_nucleotide_metabolis | 1.43119208 |
73 | MP0003633_abnormal_nervous_system | 1.42359101 |
74 | MP0005330_cardiomyopathy | 1.41377978 |
75 | MP0002184_abnormal_innervation | 1.40819792 |
76 | MP0008569_lethality_at_weaning | 1.40491401 |
77 | MP0002229_neurodegeneration | 1.40405337 |
78 | MP0004142_abnormal_muscle_tone | 1.39096978 |
79 | MP0002066_abnormal_motor_capabilities/c | 1.37941728 |
80 | MP0006138_congestive_heart_failure | 1.37773840 |
81 | MP0002557_abnormal_social/conspecific_i | 1.37112655 |
82 | MP0004811_abnormal_neuron_physiology | 1.34853389 |
83 | MP0005377_hearing/vestibular/ear_phenot | 1.33741182 |
84 | MP0003878_abnormal_ear_physiology | 1.33741182 |
85 | MP0001502_abnormal_circadian_rhythm | 1.33551064 |
86 | MP0001984_abnormal_olfaction | 1.32633578 |
87 | MP0003879_abnormal_hair_cell | 1.32059071 |
88 | MP0009250_abnormal_appendicular_skeleto | 1.30679892 |
89 | MP0003195_calcinosis | 1.30145778 |
90 | MP0000759_abnormal_skeletal_muscle | 1.29476905 |
91 | MP0002882_abnormal_neuron_morphology | 1.29266719 |
92 | MP0008004_abnormal_stomach_pH | 1.28905857 |
93 | MP0010386_abnormal_urinary_bladder | 1.28179873 |
94 | MP0004036_abnormal_muscle_relaxation | 1.26995508 |
95 | MP0005058_abnormal_lysosome_morphology | 1.26513690 |
96 | MP0005623_abnormal_meninges_morphology | 1.24884164 |
97 | MP0000750_abnormal_muscle_regeneration | 1.23946189 |
98 | MP0004782_abnormal_surfactant_physiolog | 1.23740173 |
99 | MP0003631_nervous_system_phenotype | 1.23671725 |
100 | MP0004264_abnormal_extraembryonic_tissu | 1.21440514 |
101 | MP0005535_abnormal_body_temperature | 1.20085620 |
102 | MP0003315_abnormal_perineum_morphology | 1.19747323 |
103 | MP0002972_abnormal_cardiac_muscle | 1.17491463 |
104 | MP0004742_abnormal_vestibular_system | 1.17360602 |
105 | MP0005375_adipose_tissue_phenotype | 1.17204535 |
106 | MP0010630_abnormal_cardiac_muscle | 1.14931332 |
107 | MP0000537_abnormal_urethra_morphology | 1.13793497 |
108 | MP0002837_dystrophic_cardiac_calcinosis | 1.13761189 |
109 | MP0010030_abnormal_orbit_morphology | 1.11562170 |
110 | MP0010352_gastrointestinal_tract_polyps | 1.10452872 |
111 | MP0003075_altered_response_to | 1.09617756 |
112 | MP0010329_abnormal_lipoprotein_level | 1.09586853 |
113 | MP0008260_abnormal_autophagy | 1.09586630 |
114 | MP0002896_abnormal_bone_mineralization | 1.07109697 |
115 | MP0003453_abnormal_keratinocyte_physiol | 1.06404176 |
116 | MP0005409_darkened_coat_color | 1.05892914 |
117 | MP0005645_abnormal_hypothalamus_physiol | 1.04550612 |
118 | MP0005646_abnormal_pituitary_gland | 1.03529069 |
119 | MP0005451_abnormal_body_composition | 1.02949644 |
120 | MP0000678_abnormal_parathyroid_gland | 1.02350624 |
121 | MP0001661_extended_life_span | 1.01852780 |
122 | MP0003283_abnormal_digestive_organ | 1.01240297 |
123 | MP0003632_abnormal_nervous_system | 1.00812210 |
124 | MP0005365_abnormal_bile_salt | 1.00383512 |
125 | MP0001666_abnormal_nutrient_absorption | 0.99060877 |
126 | MP0004019_abnormal_vitamin_homeostasis | 0.98423909 |
127 | MP0001765_abnormal_ion_homeostasis | 0.97451795 |
128 | MP0000762_abnormal_tongue_morphology | 0.96244142 |
129 | MP0005551_abnormal_eye_electrophysiolog | 0.95627679 |
130 | MP0001485_abnormal_pinna_reflex | 0.94869816 |
131 | MP0002069_abnormal_eating/drinking_beha | 0.94639744 |
132 | MP0000534_abnormal_ureter_morphology | 0.93623768 |
133 | MP0003172_abnormal_lysosome_physiology | 0.93368075 |
134 | MP0005620_abnormal_muscle_contractility | 0.92834030 |
135 | MP0002090_abnormal_vision | 0.91954828 |
136 | MP0000467_abnormal_esophagus_morphology | 0.91111225 |
137 | MP0003183_abnormal_peptide_metabolism | 0.89974476 |
138 | MP0001664_abnormal_digestion | 0.89507965 |
139 | MP0005410_abnormal_fertilization | 0.89339169 |
140 | MP0003828_pulmonary_edema | 0.89155057 |
141 | MP0002089_abnormal_postnatal_growth/wei | 0.88492062 |
142 | MP0002139_abnormal_hepatobiliary_system | 0.87112415 |
143 | MP0005275_abnormal_skin_tensile | 0.87084024 |
144 | MP0001177_atelectasis | 0.86831387 |
145 | MP0002638_abnormal_pupillary_reflex | 0.86772567 |
146 | MP0005385_cardiovascular_system_phenoty | 0.85624516 |
147 | MP0001544_abnormal_cardiovascular_syste | 0.85624516 |
148 | MP0000747_muscle_weakness | 0.84356667 |
149 | MP0001963_abnormal_hearing_physiology | 0.83776847 |
150 | MP0004145_abnormal_muscle_electrophysio | 0.83546229 |
151 | MP0003638_abnormal_response/metabolism_ | 0.83243415 |
152 | MP0002269_muscular_atrophy | 0.81978118 |
153 | MP0002876_abnormal_thyroid_physiology | 0.81655407 |
154 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81600881 |
155 | MP0002152_abnormal_brain_morphology | 0.80811569 |
156 | MP0001727_abnormal_embryo_implantation | 0.80264325 |
157 | MP0001849_ear_inflammation | 0.79792096 |
158 | MP0001958_emphysema | 0.78488167 |
159 | MP0004215_abnormal_myocardial_fiber | 0.78077771 |
160 | MP0000681_abnormal_thyroid_gland | 0.77725007 |
161 | MP0000858_altered_metastatic_potential | 0.75551301 |
162 | MP0005379_endocrine/exocrine_gland_phen | 0.75120591 |
163 | MP0005360_urolithiasis | 0.74904718 |
164 | MP0002060_abnormal_skin_morphology | 0.74680415 |
165 | MP0002098_abnormal_vibrissa_morphology | 0.74246262 |
166 | MP0005083_abnormal_biliary_tract | 0.73312449 |
167 | MP0001542_abnormal_bone_strength | 0.73048330 |
168 | MP0002752_abnormal_somatic_nervous | 0.73043312 |
169 | MP0009840_abnormal_foam_cell | 0.71785065 |
170 | MP0008874_decreased_physiological_sensi | 0.71558246 |
171 | MP0005332_abnormal_amino_acid | 0.71472323 |
172 | MP0000462_abnormal_digestive_system | 0.71446895 |
173 | MP0001986_abnormal_taste_sensitivity | 0.68736162 |
174 | MP0008961_abnormal_basal_metabolism | 0.67834978 |
175 | MP0002078_abnormal_glucose_homeostasis | 0.67202698 |
176 | MP0000230_abnormal_systemic_arterial | 0.66483325 |
177 | MP0001299_abnormal_eye_distance/ | 0.64323382 |
178 | MP0002118_abnormal_lipid_homeostasis | 0.63638806 |
179 | MP0005167_abnormal_blood-brain_barrier | 0.63010822 |
180 | MP0002295_abnormal_pulmonary_circulatio | 0.62150396 |
181 | MP0003122_maternal_imprinting | 0.60158009 |
182 | MP0000003_abnormal_adipose_tissue | 0.60074001 |
183 | MP0008872_abnormal_physiological_respon | 0.59914925 |
184 | MP0005636_abnormal_mineral_homeostasis | 0.59283584 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myokymia (HP:0002411) | 5.31830820 |
2 | Neurofibrillary tangles (HP:0002185) | 5.12525697 |
3 | Focal motor seizures (HP:0011153) | 4.72076927 |
4 | Supranuclear gaze palsy (HP:0000605) | 4.57555214 |
5 | Achilles tendon contracture (HP:0001771) | 4.40129876 |
6 | Cerebral inclusion bodies (HP:0100314) | 4.32203779 |
7 | Abnormality of the Achilles tendon (HP:0005109) | 4.23543132 |
8 | Visual hallucinations (HP:0002367) | 4.08402484 |
9 | Focal seizures (HP:0007359) | 3.61399010 |
10 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.55518631 |
11 | Vertebral compression fractures (HP:0002953) | 3.52343898 |
12 | Atonic seizures (HP:0010819) | 3.43625346 |
13 | Ankle clonus (HP:0011448) | 3.34912480 |
14 | Epileptic encephalopathy (HP:0200134) | 3.20719628 |
15 | Atrioventricular block (HP:0001678) | 3.17118436 |
16 | Pheochromocytoma (HP:0002666) | 3.16723664 |
17 | Action tremor (HP:0002345) | 3.11826857 |
18 | Abnormal atrioventricular conduction (HP:0005150) | 3.09579632 |
19 | Rhabdomyolysis (HP:0003201) | 3.06352356 |
20 | Retinal dysplasia (HP:0007973) | 2.96855082 |
21 | Distal lower limb muscle weakness (HP:0009053) | 2.95869773 |
22 | Hyporeflexia of lower limbs (HP:0002600) | 2.94876405 |
23 | Dysmetria (HP:0001310) | 2.93662940 |
24 | Heart block (HP:0012722) | 2.90523809 |
25 | Exercise-induced myalgia (HP:0003738) | 2.89314638 |
26 | Right ventricular cardiomyopathy (HP:0011663) | 2.88063526 |
27 | Absence seizures (HP:0002121) | 2.83850814 |
28 | Nemaline bodies (HP:0003798) | 2.77805899 |
29 | Protrusio acetabuli (HP:0003179) | 2.77219198 |
30 | Muscle fiber inclusion bodies (HP:0100299) | 2.76895959 |
31 | Dialeptic seizures (HP:0011146) | 2.76783339 |
32 | Neuroendocrine neoplasm (HP:0100634) | 2.76450297 |
33 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.75092819 |
34 | Trismus (HP:0000211) | 2.75052954 |
35 | Intention tremor (HP:0002080) | 2.73958816 |
36 | Anxiety (HP:0000739) | 2.73639327 |
37 | Spastic gait (HP:0002064) | 2.72295389 |
38 | Vascular calcification (HP:0004934) | 2.71774381 |
39 | Bundle branch block (HP:0011710) | 2.71453616 |
40 | Generalized tonic-clonic seizures (HP:0002069) | 2.70573314 |
41 | Type 1 muscle fiber predominance (HP:0003803) | 2.69043794 |
42 | Increased circulating renin level (HP:0000848) | 2.68781566 |
43 | Peripheral hypomyelination (HP:0007182) | 2.67657437 |
44 | Gout (HP:0001997) | 2.65904489 |
45 | Cardiovascular calcification (HP:0011915) | 2.60927228 |
46 | Myoglobinuria (HP:0002913) | 2.60366413 |
47 | Abnormal eating behavior (HP:0100738) | 2.60137103 |
48 | Abnormality of the corticospinal tract (HP:0002492) | 2.56474530 |
49 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.54988077 |
50 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.54988077 |
51 | Depression (HP:0000716) | 2.54053922 |
52 | Elbow flexion contracture (HP:0002987) | 2.53239195 |
53 | Mutism (HP:0002300) | 2.52968013 |
54 | Megalencephaly (HP:0001355) | 2.52130697 |
55 | Premature rupture of membranes (HP:0001788) | 2.51876409 |
56 | Axonal loss (HP:0003447) | 2.50887899 |
57 | Myopathic facies (HP:0002058) | 2.48908761 |
58 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.48411519 |
59 | Ventricular tachycardia (HP:0004756) | 2.47756273 |
60 | Increased connective tissue (HP:0009025) | 2.44982854 |
61 | Delusions (HP:0000746) | 2.44901215 |
62 | Progressive cerebellar ataxia (HP:0002073) | 2.43886566 |
63 | Hypokalemic alkalosis (HP:0001949) | 2.43135016 |
64 | Abnormality of the nasal mucosa (HP:0000433) | 2.41418308 |
65 | Ileus (HP:0002595) | 2.41135875 |
66 | Increased serum pyruvate (HP:0003542) | 2.41013547 |
67 | Type II lissencephaly (HP:0007260) | 2.40810911 |
68 | Scanning speech (HP:0002168) | 2.39929518 |
69 | Hyperparathyroidism (HP:0000843) | 2.39171785 |
70 | Truncal ataxia (HP:0002078) | 2.34879196 |
71 | Insidious onset (HP:0003587) | 2.31457777 |
72 | Termporal pattern (HP:0011008) | 2.31457777 |
73 | Vacuolated lymphocytes (HP:0001922) | 2.29895305 |
74 | Hyperactive renin-angiotensin system (HP:0000841) | 2.28109938 |
75 | Osteolytic defects of the hand bones (HP:0009699) | 2.25822244 |
76 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.25822244 |
77 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.25567743 |
78 | Akinesia (HP:0002304) | 2.25442952 |
79 | Nasal polyposis (HP:0100582) | 2.24944991 |
80 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.24929345 |
81 | Polyphagia (HP:0002591) | 2.24865328 |
82 | Postural instability (HP:0002172) | 2.22357248 |
83 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.21027610 |
84 | Abnormality of magnesium homeostasis (HP:0004921) | 2.20348295 |
85 | Progressive inability to walk (HP:0002505) | 2.18778096 |
86 | Paralysis (HP:0003470) | 2.18599926 |
87 | Epileptiform EEG discharges (HP:0011182) | 2.17792246 |
88 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17653240 |
89 | Hydroxyprolinuria (HP:0003080) | 2.17525185 |
90 | Abnormality of proline metabolism (HP:0010907) | 2.17525185 |
91 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.16615492 |
92 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.16615492 |
93 | Limb dystonia (HP:0002451) | 2.16342743 |
94 | Cerebral hemorrhage (HP:0001342) | 2.16095492 |
95 | Urinary urgency (HP:0000012) | 2.15131705 |
96 | Hypertriglyceridemia (HP:0002155) | 2.13659453 |
97 | Rigidity (HP:0002063) | 2.12814889 |
98 | Scapular winging (HP:0003691) | 2.12763540 |
99 | Torticollis (HP:0000473) | 2.11236450 |
100 | Increased variability in muscle fiber diameter (HP:0003557) | 2.10391164 |
101 | Hypsarrhythmia (HP:0002521) | 2.09105453 |
102 | Abnormality of glycolysis (HP:0004366) | 2.08375007 |
103 | Neuronal loss in central nervous system (HP:0002529) | 2.08306867 |
104 | Hypomagnesemia (HP:0002917) | 2.07102694 |
105 | Clonus (HP:0002169) | 2.06396976 |
106 | Poor eye contact (HP:0000817) | 2.06252174 |
107 | Spinal rigidity (HP:0003306) | 2.06206851 |
108 | Lipoatrophy (HP:0100578) | 2.05976717 |
109 | Cerebral hypomyelination (HP:0006808) | 2.05000799 |
110 | Muscle stiffness (HP:0003552) | 2.04101307 |
111 | Metabolic alkalosis (HP:0200114) | 2.04070558 |
112 | Lower limb muscle weakness (HP:0007340) | 2.03969735 |
113 | Split foot (HP:0001839) | 2.03262661 |
114 | Febrile seizures (HP:0002373) | 2.02882090 |
115 | Focal dystonia (HP:0004373) | 2.02865991 |
116 | Dysdiadochokinesis (HP:0002075) | 2.02589139 |
117 | Bradykinesia (HP:0002067) | 2.01053615 |
118 | Rapidly progressive (HP:0003678) | 2.00474328 |
119 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.99544528 |
120 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.99409978 |
121 | Neck muscle weakness (HP:0000467) | 1.98549007 |
122 | Renal salt wasting (HP:0000127) | 1.97699914 |
123 | Sudden death (HP:0001699) | 1.95706311 |
124 | Generalized myoclonic seizures (HP:0002123) | 1.95327695 |
125 | Short nail (HP:0001799) | 1.95145765 |
126 | Hyperventilation (HP:0002883) | 1.94562211 |
127 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94391665 |
128 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94391665 |
129 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94391665 |
130 | Amblyopia (HP:0000646) | 1.93559576 |
131 | Thickened helices (HP:0000391) | 1.91986273 |
132 | Craniofacial dystonia (HP:0012179) | 1.91413253 |
133 | Abnormal social behavior (HP:0012433) | 1.91378394 |
134 | Impaired social interactions (HP:0000735) | 1.91378394 |
135 | Psychosis (HP:0000709) | 1.91144544 |
136 | Hyperaldosteronism (HP:0000859) | 1.91003502 |
137 | Beaking of vertebral bodies (HP:0004568) | 1.90647457 |
138 | Hemiparesis (HP:0001269) | 1.90026929 |
139 | Ragged-red muscle fibers (HP:0003200) | 1.89205098 |
140 | EMG: myopathic abnormalities (HP:0003458) | 1.89152432 |
141 | Distal lower limb amyotrophy (HP:0008944) | 1.89037025 |
142 | Dysostosis multiplex (HP:0000943) | 1.88420959 |
143 | Flat acetabular roof (HP:0003180) | 1.88362622 |
144 | Increased mean platelet volume (HP:0011877) | 1.88237035 |
145 | Progressive muscle weakness (HP:0003323) | 1.88120780 |
146 | Menorrhagia (HP:0000132) | 1.87688080 |
147 | Gaze-evoked nystagmus (HP:0000640) | 1.87103368 |
148 | Pathologic fracture (HP:0002756) | 1.87063552 |
149 | Dilated cardiomyopathy (HP:0001644) | 1.86765012 |
150 | Spastic tetraparesis (HP:0001285) | 1.86228877 |
151 | Ventricular arrhythmia (HP:0004308) | 1.84523612 |
152 | Abnormality of renin-angiotensin system (HP:0000847) | 1.84170611 |
153 | Papilledema (HP:0001085) | 1.83960001 |
154 | Asymmetric septal hypertrophy (HP:0001670) | 1.83229273 |
155 | Hyperammonemia (HP:0001987) | 1.82589198 |
156 | Broad-based gait (HP:0002136) | 1.82566239 |
157 | Ventricular fibrillation (HP:0001663) | 1.81724074 |
158 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.81037244 |
159 | Abnormality of the umbilical cord (HP:0010881) | 1.79131156 |
160 | Sensory axonal neuropathy (HP:0003390) | 1.78827557 |
161 | Hyperphosphatemia (HP:0002905) | 1.78730679 |
162 | Bone pain (HP:0002653) | 1.78658131 |
163 | Abnormal gallbladder physiology (HP:0012438) | 1.78375054 |
164 | Cholecystitis (HP:0001082) | 1.78375054 |
165 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.78079217 |
166 | Cervical subluxation (HP:0003308) | 1.77830264 |
167 | Onion bulb formation (HP:0003383) | 1.77229156 |
168 | Back pain (HP:0003418) | 1.76851236 |
169 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.76070054 |
170 | Polycythemia (HP:0001901) | 1.75917354 |
171 | Global brain atrophy (HP:0002283) | 1.75497146 |
172 | Ketoacidosis (HP:0001993) | 1.74314292 |
173 | Increased muscle lipid content (HP:0009058) | 1.74281984 |
174 | Resting tremor (HP:0002322) | 1.73907576 |
175 | Sparse eyelashes (HP:0000653) | 1.73631439 |
176 | Clumsiness (HP:0002312) | 1.72867853 |
177 | Purpura (HP:0000979) | 1.72650883 |
178 | Agitation (HP:0000713) | 1.72076833 |
179 | Tetraparesis (HP:0002273) | 1.71472770 |
180 | Skin nodule (HP:0200036) | 1.71445518 |
181 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.70689031 |
182 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.70689031 |
183 | Single umbilical artery (HP:0001195) | 1.70689031 |
184 | Vascular tortuosity (HP:0004948) | 1.70415347 |
185 | Shawl scrotum (HP:0000049) | 1.69823614 |
186 | Renal tubular acidosis (HP:0001947) | 1.68359763 |
187 | Xanthomatosis (HP:0000991) | 1.67988025 |
188 | Chronic otitis media (HP:0000389) | 1.67313183 |
189 | Abnormal cartilage morphology (HP:0002763) | 1.66080691 |
190 | Abnormality of the acetabulum (HP:0003170) | 1.64344650 |
191 | Tetraplegia (HP:0002445) | 1.64115142 |
192 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.63910150 |
193 | Ulnar deviation of the wrist (HP:0003049) | 1.63526451 |
194 | Hyperthyroidism (HP:0000836) | 1.62543007 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K9 | 3.59544690 |
2 | EPHA4 | 3.51627495 |
3 | EIF2AK1 | 3.28726801 |
4 | NTRK3 | 3.06631971 |
5 | TESK1 | 2.93080537 |
6 | MYLK | 2.92570814 |
7 | EPHA2 | 2.86305362 |
8 | NTRK1 | 2.81541683 |
9 | ARAF | 2.76982731 |
10 | KSR2 | 2.75537289 |
11 | MST1R | 2.64269821 |
12 | TRIB3 | 2.63920696 |
13 | STK39 | 2.63040900 |
14 | OXSR1 | 2.50980748 |
15 | MARK1 | 2.36261402 |
16 | DAPK2 | 2.20578112 |
17 | PAK6 | 2.17603455 |
18 | TGFBR2 | 2.16996813 |
19 | RIPK4 | 2.16286324 |
20 | MINK1 | 2.14956818 |
21 | WNK4 | 2.09275777 |
22 | PRKD3 | 1.97293756 |
23 | DMPK | 1.88884671 |
24 | PDK2 | 1.86641420 |
25 | NME2 | 1.84997083 |
26 | MAP3K4 | 1.83300632 |
27 | PBK | 1.81827928 |
28 | MAP3K2 | 1.69196162 |
29 | TTN | 1.67052773 |
30 | CAMKK2 | 1.64018953 |
31 | MOS | 1.63931134 |
32 | CDK19 | 1.62957934 |
33 | MAP2K7 | 1.60022512 |
34 | PRKD2 | 1.59826671 |
35 | OBSCN | 1.59364654 |
36 | TESK2 | 1.55112681 |
37 | GRK7 | 1.54854455 |
38 | RIPK1 | 1.45586578 |
39 | PAK4 | 1.44270710 |
40 | MAP3K12 | 1.42309055 |
41 | SIK1 | 1.41895303 |
42 | CDK5 | 1.40598748 |
43 | MAP3K13 | 1.38417278 |
44 | UHMK1 | 1.38304482 |
45 | KSR1 | 1.37916795 |
46 | PNCK | 1.36593532 |
47 | GRK5 | 1.34365936 |
48 | PIK3CA | 1.28900945 |
49 | LIMK1 | 1.27654495 |
50 | IRAK3 | 1.27115263 |
51 | CAMKK1 | 1.24816739 |
52 | WNK3 | 1.23791845 |
53 | LRRK2 | 1.23159260 |
54 | BCR | 1.21407445 |
55 | EPHB2 | 1.21216696 |
56 | BMX | 1.20909422 |
57 | ILK | 1.20595146 |
58 | MAPKAPK3 | 1.20056014 |
59 | MAP2K4 | 1.19991641 |
60 | CAMK2B | 1.19353400 |
61 | PRPF4B | 1.18698438 |
62 | SGK494 | 1.15004321 |
63 | SGK223 | 1.15004321 |
64 | LATS2 | 1.13542340 |
65 | NEK1 | 1.10312059 |
66 | NTRK2 | 1.09553163 |
67 | CSNK1G2 | 1.09189186 |
68 | PINK1 | 1.09018734 |
69 | PKN2 | 1.08621903 |
70 | PHKG2 | 1.08342056 |
71 | PHKG1 | 1.08342056 |
72 | TNIK | 1.07865394 |
73 | MAP2K3 | 1.06232484 |
74 | PAK3 | 1.05083760 |
75 | PRKCG | 0.98182599 |
76 | SMG1 | 0.97490487 |
77 | CDK14 | 0.96849732 |
78 | TYRO3 | 0.96266745 |
79 | CAMK2A | 0.95381221 |
80 | MAP3K1 | 0.94760551 |
81 | PDPK1 | 0.93969956 |
82 | CAMK2G | 0.92368602 |
83 | CAMK2D | 0.89603956 |
84 | CSNK1G3 | 0.88846251 |
85 | MAP3K3 | 0.88497098 |
86 | MET | 0.87722613 |
87 | ERN1 | 0.86544212 |
88 | NME1 | 0.86403835 |
89 | PRKCH | 0.86304727 |
90 | WNK1 | 0.85977255 |
91 | PDGFRA | 0.85871992 |
92 | DAPK1 | 0.85195789 |
93 | PLK2 | 0.84184069 |
94 | PTK2B | 0.83638551 |
95 | BRAF | 0.83535626 |
96 | MAPKAPK5 | 0.83111862 |
97 | CDK18 | 0.82294822 |
98 | PAK1 | 0.82251144 |
99 | CDK15 | 0.81713956 |
100 | PTK6 | 0.79758137 |
101 | FGR | 0.79156071 |
102 | TAOK2 | 0.76843035 |
103 | RAF1 | 0.76608330 |
104 | CASK | 0.74975094 |
105 | MAPK15 | 0.74720386 |
106 | FGFR2 | 0.74155550 |
107 | MST4 | 0.73694440 |
108 | LMTK2 | 0.72075495 |
109 | MAP3K11 | 0.71617524 |
110 | STK16 | 0.71604813 |
111 | RET | 0.70829991 |
112 | BMPR2 | 0.70527965 |
113 | EPHB1 | 0.70312463 |
114 | CDK11A | 0.69816057 |
115 | MAP2K1 | 0.66826721 |
116 | PDK1 | 0.66503768 |
117 | ERBB4 | 0.64228490 |
118 | PRKD1 | 0.64075103 |
119 | BRSK1 | 0.63923865 |
120 | PRKCE | 0.63604996 |
121 | AURKA | 0.63236972 |
122 | MAPK13 | 0.62620330 |
123 | NEK6 | 0.62522563 |
124 | RPS6KA2 | 0.62256413 |
125 | MAP3K5 | 0.61508351 |
126 | CSNK1A1L | 0.60592022 |
127 | ROCK2 | 0.60488300 |
128 | PAK2 | 0.60045450 |
129 | PKN1 | 0.59647822 |
130 | PIM2 | 0.58230007 |
131 | FES | 0.57256218 |
132 | STK10 | 0.57199058 |
133 | ICK | 0.56412723 |
134 | DYRK3 | 0.56149577 |
135 | PRKG2 | 0.55575545 |
136 | PRKCZ | 0.55239857 |
137 | STK38 | 0.54234485 |
138 | AKT2 | 0.53233481 |
139 | PRKAA2 | 0.53201948 |
140 | CSNK1G1 | 0.52203374 |
141 | DYRK1A | 0.52041151 |
142 | MUSK | 0.50295663 |
143 | VRK2 | 0.49545478 |
144 | MAPK12 | 0.49448391 |
145 | NEK9 | 0.49014514 |
146 | MAPKAPK2 | 0.48878303 |
147 | MARK2 | 0.46596697 |
148 | FER | 0.45289397 |
149 | STK11 | 0.44254763 |
150 | CAMK1 | 0.43959172 |
151 | DAPK3 | 0.43733851 |
152 | BRSK2 | 0.42963996 |
153 | MAP3K6 | 0.42279758 |
154 | DYRK2 | 0.41976253 |
155 | TAOK1 | 0.41588960 |
156 | FYN | 0.41193983 |
157 | SGK3 | 0.40233647 |
158 | INSRR | 0.40229786 |
159 | BUB1 | 0.38608124 |
160 | PTK2 | 0.38164656 |
161 | MTOR | 0.38019083 |
162 | SCYL2 | 0.37222192 |
163 | CAMK1G | 0.37069091 |
164 | PRKCI | 0.36689012 |
165 | ABL2 | 0.35862284 |
166 | PRKCD | 0.31644181 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.30917937 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.66886381 |
3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.57872345 |
4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.47466945 |
5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.36978309 |
6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.31491829 |
7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.08238802 |
8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97881094 |
9 | Insulin secretion_Homo sapiens_hsa04911 | 1.97166894 |
10 | Circadian entrainment_Homo sapiens_hsa04713 | 1.97111563 |
11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.95201239 |
12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.94712823 |
13 | Galactose metabolism_Homo sapiens_hsa00052 | 1.94496759 |
14 | Morphine addiction_Homo sapiens_hsa05032 | 1.91117010 |
15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89362517 |
16 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.88491941 |
17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.84491198 |
18 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.84458066 |
19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.79051331 |
20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.74834563 |
21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72897138 |
22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.72090897 |
23 | Salivary secretion_Homo sapiens_hsa04970 | 1.68259953 |
24 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.66626105 |
25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.63243333 |
26 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.60782083 |
27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.58497111 |
28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.58427758 |
29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.56860580 |
30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.52550089 |
31 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.50744815 |
32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.49522828 |
33 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.49495904 |
34 | Cocaine addiction_Homo sapiens_hsa05030 | 1.49139635 |
35 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.48740341 |
36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48299907 |
37 | Taste transduction_Homo sapiens_hsa04742 | 1.47765053 |
38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.47325206 |
39 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.45606352 |
40 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.45208879 |
41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31030564 |
42 | Long-term depression_Homo sapiens_hsa04730 | 1.27353976 |
43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.26431390 |
44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.25689408 |
45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.21939678 |
46 | Alzheimers disease_Homo sapiens_hsa05010 | 1.21298119 |
47 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.20129963 |
48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20018104 |
49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19850088 |
50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19371276 |
51 | Renin secretion_Homo sapiens_hsa04924 | 1.19022784 |
52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15358916 |
53 | Lysosome_Homo sapiens_hsa04142 | 1.13421716 |
54 | Parkinsons disease_Homo sapiens_hsa05012 | 1.13411938 |
55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.13260274 |
56 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12367223 |
57 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.11126211 |
58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.09499870 |
59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08350772 |
60 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08133732 |
61 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07901553 |
62 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06833356 |
63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06563189 |
64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.06552609 |
65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06189721 |
66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04828203 |
67 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03837946 |
68 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01605041 |
69 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.01416258 |
70 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00186731 |
71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.99691131 |
72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97809360 |
73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96801889 |
74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96381106 |
75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95529177 |
76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95239484 |
77 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94445812 |
78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93635492 |
79 | Gap junction_Homo sapiens_hsa04540 | 0.93232614 |
80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.92922773 |
81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.92020463 |
82 | Mineral absorption_Homo sapiens_hsa04978 | 0.91993740 |
83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91511794 |
84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90052961 |
85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.89328294 |
86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.88898830 |
87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.88344738 |
88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88242829 |
89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87230178 |
90 | Proteasome_Homo sapiens_hsa03050 | 0.85838495 |
91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84000468 |
92 | Axon guidance_Homo sapiens_hsa04360 | 0.83742841 |
93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.83691023 |
94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83461859 |
95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82253638 |
96 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80877845 |
97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80626397 |
98 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80230964 |
99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79516629 |
100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77380545 |
101 | Prion diseases_Homo sapiens_hsa05020 | 0.76562318 |
102 | Focal adhesion_Homo sapiens_hsa04510 | 0.76071451 |
103 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75415857 |
104 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74805632 |
105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.74310407 |
106 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73564499 |
107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73463012 |
108 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72140074 |
109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72070109 |
110 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71621252 |
111 | Tight junction_Homo sapiens_hsa04530 | 0.71590849 |
112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71493615 |
113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68797344 |
114 | Protein export_Homo sapiens_hsa03060 | 0.68639346 |
115 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.68095762 |
116 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67108204 |
117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66610208 |
118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66593755 |
119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66231140 |
120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65803866 |
121 | Endocytosis_Homo sapiens_hsa04144 | 0.64274366 |
122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63767211 |
123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63253055 |
124 | Bile secretion_Homo sapiens_hsa04976 | 0.62357335 |
125 | Melanogenesis_Homo sapiens_hsa04916 | 0.61557061 |
126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61521177 |
127 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61259305 |
128 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61215871 |
129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59983606 |
130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58831348 |
131 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58504755 |
132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57614195 |
133 | Phagosome_Homo sapiens_hsa04145 | 0.56244152 |
134 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53153776 |
135 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52919053 |
136 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52836786 |
137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52496558 |
138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51604002 |
139 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51075716 |
140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50338898 |
141 | Glioma_Homo sapiens_hsa05214 | 0.49878749 |
142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45929711 |
143 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45678032 |
144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45295489 |
145 | Ribosome_Homo sapiens_hsa03010 | 0.44739705 |
146 | Peroxisome_Homo sapiens_hsa04146 | 0.44532809 |
147 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43191560 |
148 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42877276 |
149 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42244974 |
150 | Phototransduction_Homo sapiens_hsa04744 | 0.39085252 |
151 | Adherens junction_Homo sapiens_hsa04520 | 0.38956174 |
152 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38657689 |
153 | Bladder cancer_Homo sapiens_hsa05219 | 0.38555227 |
154 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.37277317 |
155 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37163610 |
156 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36881042 |
157 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35924248 |
158 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35835410 |
159 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35108053 |
160 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35099780 |
161 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.34425393 |
162 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33305404 |
163 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33142696 |